Good News! CE Mark Approval for Bioperfectus Monkeypox Virus Real Time PCR Kit

Company news

Shanghai, China, 25th May 2022—We Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) solemnly announce that we have received CE mark approval for Monkeypox Virus Real Time PCR Kit. With CE mark approval, Bioperfectus Monkeypox Virus Real Time PCR Kit is now available for the European Union and other countries and regions in recognition of CE certification as monkeypox virus threats are still mounting in many non-endemic countries.


According to WHO, polymerase chain reaction (PCR) is the preferred laboratory test given its accuracy and sensitivity. The Bioperfectus Monkeypox Virus Real Time PCR Kit is based on real-time PCR technology. Specific primers and probes are designed based on F3L gene areas of the Monkeypox virus. In addition, the kit also contains a housekeeping gene (RNase P) as an internal control (IC) for specimen sampling and nucleic acid extraction.


As an essential addition to Bioperfectus Total PCR Solution, Bioperfectus Monkey Virus Real Time PCR Kit applies to Bioperfectus Nucleic Acid Extraction Solution, Bioperfectus STC-96A, STC-96A PLUS Real-Time PCR System, and other primary PCR instruments in the market.


At the same time, Bioperfectus Monkeypox Virus Real Time PCR Kit can also detect veterinary samples with an exogenous internal control. For more information, please get in touch with your sales representative via



About Bioperfectus

Bioperfectus, a public listed company on Shanghai Stock Exchange (SSE:688399), has been one of the leading molecular diagnostic solution providers specializing in infectious diseases ever since 2010. With headquarters located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream of creating a healthier future for our next generations. For more information, please follow us on LinkedIn or visit





Bioperfectus Monkeypox Virus PCR Kit to Support Testing Across Africa

Mr. TUNC MERT SAYIN addressed the opening ceremony of the Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique held by Africa Centers for Disease Control and Prevention in collaboration with Nigeria Center for Disease Control (Nigeria CDC) and Africa Society for Laboratory Medicine (ASLM).


Next pandemic? Concerns growing as monkeypox virus cases surge

On 17 June, the WHO released its latest update on the Monkeypox outbreak situation. The sharp growth of confirmed cases during the last two months indicates increasing uncertainty of the endemic progress. Between 1 January and 15 June 2022, a cumulative total of 2103 laboratory confirmed cases, one probable case, and one death were laboratory-confirmed had reported to WHO from 42 countries in five WHO Regions. The majority of cases (98%) have been reported since May 2022. Most cases are recognized and reported from European countries, followed by the American region.


Bioperfectus Real-Time PCR Systems Included in FDA-listed for IVD Testing

Today, we Bioperfectus are proud to announce that STC-96A and STC-96A PLUS Real-Time PCR Systems have been listed with the U.S. Food and Drug Administration (FDA) for IVD testing. With FDA registration, Bioperfectus Real-Time PCR Systems obtained access to PCR laboratories in the US. With stable performance and user-friendly design, STC-96A and STC-96A Plus will be great helpers for molecular laboratories to identify the virus and bacterial.